However, our computational analysis of several neuroblastoma and adrenal medulla datasets combined with functional experiments in vitro and in vivo preclinical models of neuroblastoma suggest that HIF2α is not an oncogene in neuroblastoma but potentially harbors tumor suppressive characteristics, which are probably connected to the reduction of MYCN protein levels. This evidence concerns the gene EPAS1 and neuroblastoma.